Christopher Van Tuyl is Chief Legal Officer of Immunovant, Inc.. Currently has a direct ownership of 149,930 shares of IMVT, which is worth approximately $4.12 Million. The most recent transaction as insider was on Dec 18, 2025, when has been sold 10,813 shares (Common Stock) at a price of $27.08 per share, resulting in proceeds of $292,816. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 150K
6.73% 3M change
36.35% 12M change
Total Value Held $4.12 Million

Christopher Van Tuyl Transaction History

Date Transaction Value Shares Traded Shares Held Form
Dec 18 2025
SELL
Open market or private sale
$292,816 $27.08 p/Share
10,813 Reduced 6.73%
149,930 Common Stock
Apr 01 2025
BUY
Grant, award, or other acquisition
-
50,787 Added 24.01%
160,743 Common Stock
Dec 16 2024
BUY
Grant, award, or other acquisition
-
109,956 Added 50.0%
109,956 Common Stock
CVT

Christopher Van Tuyl

Chief Legal Officer
New York, NY

Track Institutional and Insider Activities on IMVT

Follow Immunovant, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells IMVT shares.

Notify only if

Insider Trading

Get notified when an Immunovant, Inc. insider buys or sells IMVT shares.

Notify only if

News

Receive news related to Immunovant, Inc.

Track Activities on IMVT